The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


OXB OXFORD BIOMEDICA PLC ORD 1P

OXFORD BIOMED.  Currency  GBX  Premium Equity Commercial Companies



 Page 3 of 3

Previous | 1 | 2 | 3 |

Time/Date Code Headline Source Impact
07:00 29-Apr-2014 OXB Oxford BioMedica provides update on RetinoStat® RNS +1.30% Up
07:00 10-Apr-2014 OXB Final Results RNS -7.04% Down
07:00 07-Apr-2014 OXB OXB completes patient recruitment into RetinoStat RNS -5.31% Down
07:00 03-Apr-2014 OXB Notice of Results RNS -4.20% Down
07:00 21-Mar-2014 OXB OXB Present at Regen Med Investor Day RNS -10.00% Down
07:00 17-Feb-2014 OXB Oxford BioMedica and Sanofi Amend Terms for Ocular RNS +2.99% Up
16:40 17-Jan-2014 OXB Second Price Monitoring Extn RNS +6.43% Up
16:35 17-Jan-2014 OXB Price Monitoring Extension RNS +6.43% Up
07:00 10-Jan-2014 OXB Publication of ProSavin Phase I/II Study RNS +32.15% Up
12:19 09-Jan-2014 OXB Oxford BioMedica to Present at Biotech Showcase RNS +30.53% Up
10:28 06-Jan-2014 OXB Oxford Biomedica PLC - General Meeting RNS +14.62% Up
07:00 18-Dec-2013 OXB OXB option agreement with GSK RNS +11.23% Up

 Page 3 of 3

Previous | 1 | 2 | 3 |

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


OXFORD BIOMED. share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds